1. Home
  2. Live Updates
  3. Novarock biotherapeutics

Live Breaking News & Updates on Novarock biotherapeutics

Stay informed with the latest breaking news from Novarock biotherapeutics on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Novarock biotherapeutics and stay connected to the pulse of your community

Global Bispecific Antibody Market Clinical Trials Insight Report to 2029: 12 Bispecific Antibodies Generated Revenue of Over US$ 8.5 Billion in 2023

/PRNewswire/ -- The "Global Bispecific Antibody Market, Drugs Sales, Patent, Price & Clinical Trials Insight 2029" report has been added to...

Dublin , Ireland , Gensun-biopharma , Lyvgen-biopharma , Immuneonco-biopharma , Novarock-biotherapeutics , Astellas-pharma , Laura-wood , Epimab-biotherapeutics , Linton-pharm , Innovent-biologics , Akeso-biopharma

Leap Therapeutics Reports Third Quarter 2023 Financial Results

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported...

Cambridge , Cambridgeshire , United-kingdom , Australia , China , Australian , Matthew-deyoung , Novarock-biotherapeutics , Douglase-onsi , Nasdaq , Drug-administration , Leap-therapeutics-inc

United States Bispecific Antibodies Market & Clinical Pipeline Insight Report 2023-2028: Market Revolutionizes Cancer Treatment and Infectious Disease Control

/PRNewswire/ -- The "US Bispecific Antibodies Market & Clinical Pipeline Insight 2028" drug pipelines has been added to ResearchAndMarkets.com's offering. The...

Dublin , Ireland , Epimab-biotherapeutics , Laura-wood , Novarock-biotherapeutics , Innovent-biologics , Bristol-myers-squibb , Amberstone-biosciences , Astellas-pharma , Pfizer , Us-bispecific-antibodies-clinical-pipeline-by-company , E-st-office-hours-call

Leap Therapeutics Reports Second Quarter 2023 Financial Results

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported...

United-states , Cambridge , Cambridgeshire , United-kingdom , Australia , China , Australian , American , Douglase-onsi , Matthew-deyoung , Novarock-biotherapeutics , Leap-therapeutics-inc

Leap Therapeutics Announces Initiation of Randomized Controlled Part B of the DeFianCe Study of DKN-01 in Colorectal Cancer Patients

CAMBRIDGE, Mass., July 12, 2023 /PRNewswire/ -- Leap Therapeutics, Inc. , a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that, based on the...

Cambridge , Cambridgeshire , United-kingdom , China , Douglase-onsi , Zev-wainberg , Matthew-deyoung , Novarock-biotherapeutics , Cynthia-sirard , Ucla-gi-oncology-program , Leap-therapeutics-inc , Prnewswire-leap-therapeutics-inc

Leap Therapeutics Announces Reverse Stock Split

CAMBRIDGE, Mass., June 20, 2023 /PRNewswire/ -- Leap Therapeutics, Inc. , a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that it will effect... | June 20, 2023

Cambridge , Cambridgeshire , United-kingdom , China , Douglase-onsi , Matthew-deyoung , Novarock-biotherapeutics , Leap-therapeutics-inc , Nasdaq , Drug-administration , Continental-stock-transfer-trust-company , Prnewswire-leap-therapeutics-inc

Leap Therapeutics to Present Updated Data from Part A of the DisTinGuish Study of DKN-01 Plus Tislelizumab and Chemotherapy in Gastric Cancer Patients at the 2023 ASCO Annual Meeting

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today...

China , United-states , Cambridge , Cambridgeshire , United-kingdom , South-korea , Germany , Chicago , Illinois , Republic-of-korea , American , Samuel-klempner

Leap Therapeutics to Present Updated Data from Part A of the DisTinGuish Study of DKN-01 Plus Tislelizumab and Chemotherapy in Gastric Cancer Patients at the 2023 ASCO Annual Meeting

Leap Therapeutics to Present Updated Data from Part A of the DisTinGuish Study of DKN-01 Plus Tislelizumab and Chemotherapy in Gastric Cancer Patients at the 2023 ASCO Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Germany , Chicago , Illinois , United-states , United-kingdom , China , South-korea , Cambridge , Cambridgeshire , Republic-of-korea , American , Douglase-onsi

Bispecific Antibody Global Market Forecast to 2028: Approved Bispecific Antibodies Pricing and Dosage Analysis

/PRNewswire/ -- The "Global Bispecific Antibody Market Opportunity and Clinical Trials Insight 2023" report has been added to ResearchAndMarkets.com's offering....

United-states , Dublin , Ireland , China , South-korea , Australia , Japan , United-kingdom , Canada , Switzerland , Swiss , America

Global Bispecific Antibody Market Report 2023: Players

Dublin, May 16, 2023 (GLOBE NEWSWIRE) -- The "Global Bispecific Antibody Market Opportunity and Clinical Trials Insight 2023" report has been added to ...

Japan , South-korea , United-states , Canada , China , United-kingdom , Australia , Dublin , Ireland , Switzerland , America , Swiss